Improving tests for platelet function disorders
Official title: Towards Improved Diagnostics for Suspected Platelet Function Disorders
Run by Region Stockholm · NCT05985668 · Data updated 2026-11-12
This study is testing new platelet function tests to see if they can help doctors better diagnose and manage bleeding problems in patients with suspected or confirmed platelet function disorders.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Months and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Region Stockholm Government |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | September 5, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 4, 2023 |
| Trial ID | NCT05985668 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with known or suspected platelet function disorders who are being evaluated at Karolinska University Hospital.
✕Probably not a fit
Patients currently on antiplatelet or anticoagulant medications, or those with other coagulation disorders, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the diagnostic accuracy of new platelet function tests in patients with confirmed or suspected platelet function disorders. Participants will be recruited from the Coagulation Unit at Karolinska University Hospital and the Pediatric Coagulation Unit at Astrid Lindgren Children's Hospital. The goal is to enhance the effectiveness of platelet function testing during bleeding investigations, which could lead to better diagnosis and management of these disorders.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses and improved management of patients with platelet function disorders.
How similar studies have gone: While this approach is focused on improving diagnostic accuracy, similar studies have shown promise in enhancing the understanding and management of platelet function disorders.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria, known defects: * Known platelet function disorder under follow-up at Karolinska University Hospital (genetic or functional assay) * High likelihood of platelet function disorder (aberrant screening test with inheritance) * Family investigation for platelet disorder Exclusion Criteria, known defects:: * Antiplatelet or anticoagulant drugs * vWF:GPIb below 0.40 IU/mL * Hematocrit below 0.35 or above 0.50 * Other coagulation disorder Inclusion Criteria, suspected platelet function disorder: * Bleeding investigation at Karolinska University Hospital Exclusion Criteria, suspected platelet function disorder:: * Antiplatelet or anticoagulant drugs * vWF:GPIb below 0.40 IU/mL * Hematocrit below 0.35 or above 0.50 * Other coagulation disorder
Where it's running
-
Karolinska University Hospital
Stockholm, Sweden Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term observation of non-cancer blood disorders
This study is tracking people with blood disorders like hemophilia and thrombosis for at least 15 years to see how their conditions change over time and gather useful information for doctors and researchers.
-
Group CBT vs. Activity Group for Adults with ADHD
This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.
-
AI support in emergency medicine helps doctors make differential diagnoses
This study tests whether a generative AI tool can help emergency doctors arrive at more accurate differential diagnoses for adult patients at Karolinska University Hospital.
-
Predicting prostate cancer response to neoadjuvant darolutamide with a gene biomarker
This study tests whether a gene-based PCAI ImmunoScore can predict which high-risk localized or locally advanced prostate cancer patients will have minimal residual disease after 90–120 days of darolutamide before surgery.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Brief Cognitive Behavioral Therapy for Inpatient Psychiatry
This project tests whether a brief CBT program added to usual inpatient care helps adults with depression or anxiety during their hospital stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.